||Human Homo sapiens
||Çalışkan S, Gökçe AM, Gümrükçü G, Önenerk M. Renal Medullary Carcinoma A Rare Entity. Iran J Med Sci. 2017 Mar42(2):215-218 p.215 2nd paragraphPubMed ID28360450
|| Maroja Silvino MC, Venchiarutti Moniz CM, Munhoz Piotto GH, Siqueira S, Galapo Kann A, Dzik C. Renal medullary carcinoma response to chemotherapy: A referral center experience in Brazil. Rare Tumors. 2013 5:e44. doi: 10.4081/rt.2013.e44.PubMed ID24179656
||P.215 2nd paragraph: "Renal medullary carcinoma (RMC) is a very rare malignancy that accounts for less than 1% of all renal neoplasms [primary source]. RMC exhibits a highly aggressive behavior and is usually seen among young men aged between 10 and 40 years. Most patients are young African-American men [ref 2]. RMC occurs in the right kidney of more than 75% of the patients. The reported patients were associated with sickle cell hemoglobinopathy, mainly with sickle cell trait and less frequently without sickle cell disease [ref 3]."